NYSE:GRDN Guardian Pharmacy Services Q3 2025 Earnings Report $24.36 -0.05 (-0.20%) Closing price 10/16/2025 03:59 PM EasternExtended Trading$24.36 +0.00 (+0.02%) As of 10/16/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Guardian Pharmacy Services EPS ResultsActual EPSN/AConsensus EPS $0.24Beat/MissN/AOne Year Ago EPSN/AGuardian Pharmacy Services Revenue ResultsActual RevenueN/AExpected Revenue$354.15 millionBeat/MissN/AYoY Revenue GrowthN/AGuardian Pharmacy Services Announcement DetailsQuarterQ3 2025Date11/10/2025TimeAfter Market ClosesConference Call DateMonday, November 10, 2025Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Guardian Pharmacy Services Earnings HeadlinesGuardian Pharmacy files Form S-3, lock-up agreements with pre-IPO holdersOctober 15 at 2:32 AM | msn.comGuardian Pharmacy Services, Inc. (NYSE:GRDN) Receives Consensus Rating of "Moderate Buy" from BrokeragesOctober 15 at 2:01 AM | americanbankingnews.comIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of customer deposits as Americans rush into a new form of money… That’s just been authorized under President Trump’s highly controversial new law, S.1582. | Banyan Hill Publishing (Ad)Guardian Pharmacy Locks Up Majority of SharesOctober 14 at 5:31 PM | tipranks.comGuardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common StockOctober 14 at 4:47 PM | businesswire.comOppenheimer Initiates Coverage of Guardian Pharmacy Services (GRDN) with Outperform RecommendationOctober 11, 2025 | msn.comSee More Guardian Pharmacy Services Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Guardian Pharmacy Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardian Pharmacy Services and other key companies, straight to your email. Email Address About Guardian Pharmacy ServicesGuardian Pharmacy Services (NYSE:GRDN), a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.View Guardian Pharmacy Services ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Goldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Upcoming Earnings American Express (10/17/2025)HDFC Bank (10/17/2025)Truist Financial (10/17/2025)Intuitive Surgical (10/21/2025)Nasdaq (10/21/2025)Netflix (10/21/2025)PACCAR (10/21/2025)Texas Instruments (10/21/2025)Citigroup (10/21/2025)Chubb (10/21/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
